Recent Updates

Modified on: 
Jun 9, 2020

Key points

  • Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is an immune-mediated cause of thrombocytopenia in neonates due to maternal anti-human platelet antigen (HPA) antibodies, most commonly anti-HPA-1a.
  • Intracranial hemorrhage (ICH) is a serious complication of FNAIT and is estimated to affect 1 in 10,000 live births.
  • Diagnostic testing for FNAIT includes three main steps:
    • Maternal anti-HPA antibody screening and identification
    • HPA genotyping of mother, father and/or neonate
    • Confirmation of antibody specificity and reactivity with the monoclonal antibody immobilization of platelet antigens (MAIPA) assay
  • HPA-matched platelets should be given to a neonate with FNAIT if immediately available, otherwise unmatched units (random pooled platelets) should be provided until matched platelets can be obtained.
Transfusion
Modified on: 
Jun 4, 2020

The content on this page is specific for 2019-2020 Transfusion Camp. Content for 2020-2021 will start being updated approximately one month ahead of the live event held in Toronto. See General Information Schedules and Locations document for live event dates.

Reminder:

Transfusion
Modified on: 
Jun 3, 2020

Health care professionals in donation and transplantation are invited to attend a series of webinars focusing on psychological first aid, grief and loss, and moral distress, within the context of the COVID-19 pandemic. 

A severe mass event like this pandemic can cause the general public and those affected by COVID-19, including health care workers, to be mentally impacted. Psychological First Aid is an intervention method that can help people in distress during these challenging times.

Organs and Tissues
Modified on: 
May 29, 2020

Report and Recommendations

  • Donation after Cardiocirculatory Death in Canada (July 2005) PDF

Journal publications

Organs and Tissues
Modified on: 
May 29, 2020

The resources below are to support organ donation organization staff and health care professionals caring for potential DCD donors.

Organs and Tissues
Modified on: 
May 29, 2020

Organ and Tissue Donation and Transplantation (OTDT) Advisory Committees

Organs and Tissues
Modified on: 
May 29, 2020

Digital technology is transforming the way health care services are delivered in Canada. The Canadian Transplant Registry (CTR) is an example of an innovative technology that generates value in terms of quality, safety and efficiency through its capabilities for supporting all donors, candidate listing, offer management, allocation and pre and post-transplant data.  

Organs and Tissues
Modified on: 
May 29, 2020

Surveillance of National Organ Transplant Recipients Affected by COVID-19 (SNO-TRAC)

Organs and Tissues
Modified on: 
May 26, 2020

The national Kidney Paired Donation (KPD) program is an interprovincial organ sharing program operated by Canadian Blood Services in collaboration with Canada’s living kidney donation and kidney transplant programs. The KPD program gives individuals an opportunity to become a living donor and donate a kidney to someone in need, and in doing so, provide transplant candidates an increased opportunity to receive a transplant.

Organs and Tissues
Modified on: 
May 21, 2020

Natiional system performance data - 2018

Beginning in 2012, Canadian Blood Services, on behalf of the Eye and Tissue Data Committee (ETDC), received data submissions from all Canadian eye and tissue programs. Data definitions were established and data training delivered to the Canadian eye and tissue community.

Organs and Tissues

Pages